0,937  0,005  Antiinflammatory
0,906  0,005  Apoptosis agonist
0,851  0,005  Antileukemic
0,847  0,004  Bone diseases treatment
0,845  0,005  Antineoplastic (breast cancer)
0,828  0,004  Antipsoriatic
0,828  0,006  Antineoplastic (lung cancer)
0,819  0,004  Antiosteoporotic
0,816  0,004  Nitric oxide antagonist
0,805  0,005  Antineoplastic (ovarian cancer)
0,793  0,005  Sensitization
0,781  0,004  Antineoplastic (pancreatic cancer)
0,752  0,005  Antineoplastic (melanoma)
0,747  0,010  CYP2C9 substrate
0,733  0,006  CYP2C19 substrate
0,724  0,012  Antineoplastic (colorectal cancer)
0,707  0,013  Antineoplastic (colon cancer)
0,701  0,010  Prostate cancer treatment
0,688  0,004  Antineoplastic (endocrine cancer)
0,681  0,007  NOS2 expression inhibitor
0,685  0,017  Teratogen
0,660  0,004  Antialcoholic
0,666  0,018  Embryotoxic
0,655  0,007  Immunosuppressant
0,647  0,014  Carcinogenic
0,658  0,025  Transcription factor NF kappa B inhibitor
0,619  0,005  Antineoplastic (carcinoma)
0,614  0,010  AR expression inhibitor
0,616  0,012  Antineoplastic (cervical cancer)
0,615  0,015  Chemoprotective
0,618  0,022  TNF expression inhibitor
0,609  0,017  Respiratory analeptic
0,594  0,004  Antiacne
0,578  0,014  Proliferative diseases treatment
0,566  0,016  Antipruritic, allergic
0,542  0,006  Antineoplastic (liver cancer)
0,533  0,004  Antiviral (Influenza A)
0,532  0,006  Hair growth stimulant
0,529  0,012  Tumour necrosis factor alpha release inhibitor
0,520  0,008  UGT1A4 substrate
0,544  0,034  CYP3A4 substrate
0,506  0,004  Abortion inducer
0,517  0,018  Chemopreventive
0,499  0,005  Prostate disorders treatment
0,511  0,017  Antineoplastic (multiple myeloma)
0,495  0,007  Prostatic (benign) hyperplasia treatment
0,492  0,004  Antifungal enhancer
0,493  0,012  Antineoplastic enhancer
0,486  0,005  5 Hydroxytryptamine uptake stimulant
0,488  0,008  Muscle relaxant
0,482  0,005  Antiviral (Influenza)
0,480  0,007  Contraceptive
0,492  0,023  Hepatic disorders treatment
0,459  0,004  Vanilloid agonist
0,477  0,023  Apoptosis antagonist
0,473  0,025  Analeptic
0,459  0,014  UDP-glucuronosyltransferase substrate
0,451  0,007  UGT2B7 substrate
0,443  0,006  Antipruritic, non-allergic
0,444  0,009  Interferon gamma antagonist
0,460  0,025  Antineoplastic (glioma)
0,461  0,029  Immunomodulator
0,430  0,015  Calcium channel activator
0,405  0,003  Alcohol dehydrogenase substrate
0,409  0,010  Platelet adhesion inhibitor
0,448  0,051  Antiprotozoal
0,423  0,026  Antiprotozoal (Leishmania)
0,415  0,019  Angiogenesis stimulant
0,406  0,013  Hepatoprotectant
0,423  0,032  ICAM1 expression inhibitor
0,446  0,058  Antibacterial
0,421  0,039  Antifungal
0,386  0,006  CYP2B6 inhibitor
0,404  0,029  Cardiovascular analeptic
0,385  0,010  Pneumotoxic
0,381  0,008  Antidiabetic (type 1)
0,408  0,035  Cytotoxic
0,442  0,087  Caspase 9 stimulant
0,364  0,014  Antineoplastic (squamous cell carcinoma)
0,354  0,006  UGT2B9 substrate
0,372  0,028  Vasodilator
0,344  0,003  5-Alpha-reductase inhibitor
0,334  0,002  Hypercalcemia treatment
0,359  0,027  Antiulcerative
0,352  0,023  UGT1A1 substrate
0,367  0,042  Antioxidant
0,328  0,003  Actinic keratosis treatment
0,328  0,005  Farnesoid X receptor antagonist
0,327  0,004  TRPA1 agonist
0,379  0,059  Antiprotozoal (Plasmodium)
0,348  0,032  Psychostimulant
0,386  0,070  CYP2C19 inhibitor
0,357  0,049  Antiepileptic
0,362  0,055  Caspase 3 stimulant
0,343  0,039  Antineoplastic (lymphoma)
0,330  0,027  Sedative
0,332  0,034  DNA synthesis inhibitor
0,310  0,015  Sepsis treatment
0,330  0,036  Antiparasitic
0,308  0,023  Skin irritative effect
0,342  0,057  NOS3 expression inhibitor
0,304  0,020  Carcinogenic, group 3
0,282  0,003  Ca(v)3.1 blocker
0,318  0,043  Vascular (periferal) disease treatment
0,305  0,030  Antihelmintic
0,316  0,042  Mutagenic
0,299  0,033  Antiviral (HIV)
0,310  0,044  Antineoplastic (glioblastoma multiforme)
0,323  0,059  Sodium/bile acid cotransporter inhibitor
0,300  0,036  Antiparkinsonian, rigidity relieving
0,260  0,005  Aldehyde dehydrogenase substrate
0,259  0,006  Aromatase inhibitor
0,306  0,059  UGT2B4 substrate
0,252  0,008  Microtubule formation inhibitor
0,277  0,039  Antihypotensive
0,235  0,002  Vitamin D receptor antagonist
0,265  0,037  Non-steroidal antiinflammatory agent
0,266  0,045  Sigma receptor agonist
0,244  0,026  Bone formation stimulant
0,231  0,013  Antieczematic
0,288  0,072  Radioprotector
0,269  0,057  Antineoplastic (lymphocytic leukemia)
0,246  0,035  Lipocortins synthesis antagonist
0,238  0,030  Protein kinase stimulant
0,219  0,014  Choleretic
0,263  0,058  Antineoplastic (sarcoma)
0,205  0,004  Anabolic
0,224  0,023  UGT2B10 substrate
0,268  0,068  Antineoplastic (renal cancer)
0,209  0,010  Vanilloid 1 agonist
0,218  0,019  Arachidonic acid antagonist
0,207  0,013  Androgen antagonist
0,211  0,018  Expectorant
0,205  0,013  Contraceptive female
0,273  0,081  Spasmolytic
0,193  0,004  Hyperparathyroidism treatment
0,194  0,010  Transcription factor NF kappa B stimulant
0,264  0,083  5 Hydroxytryptamine release stimulant
0,236  0,055  VCAM1 expression inhibitor
0,195  0,017  Menstruation disorders treatment
0,252  0,081  Transcription factor STAT3 inhibitor
0,182  0,012  ABCA1 expression enhancer
0,197  0,030  Protein-tyrosine phosphatase 1B inhibitor
0,171  0,004  Na+ K+ transporting ATPase inhibitor
0,189  0,023  Shock treatment
0,177  0,011  Inducible nitric-oxide synthase inhibitor
0,176  0,014  Posttraumatic stress disorder treatment
0,245  0,083  Interleukin agonist
0,206  0,049  LDLR expression enhancer
0,177  0,021  Pregnane X receptor agonist
0,259  0,107  Antineoplastic (osteosarcoma)
0,167  0,023  Antineoplastic alkaloid
0,178  0,034  Antiviral (Hepatitis B)
0,192  0,050  Antiviral (Herpes)
0,147  0,006  Narcotic antagonist
0,164  0,024  GABA C receptor antagonist
0,142  0,002  Parathyroid hormone antagonist
0,147  0,008  Glycine receptor antagonist
0,164  0,028  Antineoplastic antibiotic
0,185  0,048  Melanin inhibitor
0,251  0,117  Antineoplastic (brain cancer)
0,168  0,037  Adenylate cyclase stimulant
0,146  0,017  UGT2B11 substrate
0,132  0,003  CYP24 inhibitor
0,141  0,013  Postmenopausal disorders treatment
0,215  0,087  Cytostatic
0,177  0,055  Diuretic
0,127  0,007  Progesterone antagonist
0,128  0,010  Cannabinoid CB2 receptor antagonist
0,131  0,018  Keratolytic
0,134  0,022  Paget's disease treatment
0,218  0,110  Immunostimulant
0,126  0,020  Contraceptive male
0,110  0,005  Anesthetic inhalation
0,207  0,102  Antipyretic
0,123  0,018  CDC25A inhibitor
0,118  0,014  Estrogen agonist
0,166  0,065  Protein-tyrosine phosphatase inhibitor
0,166  0,066  Uterine stimulant
0,107  0,008  Aldosterone antagonist
0,179  0,087  Anesthetic general
0,109  0,018  T cell inhibitor
0,097  0,007  Postcoital contraceptive
0,152  0,063  Skeletal muscle relaxant
0,158  0,068  Acute respiratory distress syndrome (ARDS) treatment
0,101  0,014  Androgen agonist
0,092  0,005  Retinoid X receptor agonist
0,100  0,017  Vanilloid 4 agonist
0,109  0,027  Antiprotozoal activity enhancer
0,193  0,111  RNA-directed DNA polymerase inhibitor
0,208  0,127  Transcription factor STAT inhibitor
0,251  0,171  Antineoplastic (myeloid leukemia)
0,154  0,075  Eye irritation, high
0,119  0,044  Antiviral (Coronavirus)
0,119  0,044  Antiviral (SARS coronavirus)
0,079  0,005  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,163  0,088  Antineoplastic (gastric cancer)
0,228  0,154  FMO1 substrate
0,147  0,074  Antianorexic
0,114  0,043  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,085  0,014  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,101  0,032  3C-Like protease (SARS coronavirus) inhibitor
0,107  0,038  Antispirochetal
0,080  0,013  Lipocortins synthesis agonist
0,264  0,197  Antidiabetic
0,264  0,197  Cyclophilin D inhibitor
0,103  0,038  Acetylcholine nicotinic antagonist
0,099  0,035  Antibiotic
0,069  0,004  Tubulin agonist
0,069  0,006  5-Alpha-reductase 1 inhibitor
0,142  0,082  Acetylcholine M1 receptor antagonist
0,064  0,005  Kainate receptor agonist
0,144  0,085  Movement disorders treatment
0,073  0,014  Potassium channel Kv1.3 blocker
0,072  0,016  Lysine-specific demethylase 1A inhibitor
0,169  0,113  Dependence treatment
0,156  0,101  Succinate dehydrogenase inhibitor
0,106  0,051  Nitric-oxide synthase inhibitor
0,064  0,010  Microtubule stabilization
0,115  0,064  Estrogen antagonist
0,077  0,028  Glutamate (mGluR6) antagonist
0,165  0,116  Neurotrophic factor enhancer
0,099  0,050  Antiviral (Rhinovirus)
0,056  0,007  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,060  0,013  Glutamate (mGluR group III) antagonist
0,052  0,005  Progesterone agonist
0,098  0,053  Bile acid receptor antagonist
0,048  0,003  Vanilloid 2 agonist
0,130  0,086  UGT2B15 substrate
0,107  0,063  Antiprotozoal (Toxoplasma)
0,056  0,013  Glucocorticoid antagonist
0,140  0,097  Antihelmintic (Nematodes)
0,099  0,056  Prolactin inhibitor
0,047  0,007  5-Alpha-reductase 2 inhibitor
0,113  0,074  Autism spectrum disorders treatment
0,043  0,004  Progesterone receptor B antagonist
0,057  0,018  Estrogen receptor beta agonist
0,120  0,082  Anesthetic
0,151  0,114  Antiviral (Hepatitis)
0,106  0,070  Mucolytic
0,083  0,047  Nicotinic alpha4beta2 receptor antagonist
0,049  0,015  Retinoid X alpha receptor agonist
0,090  0,056  Ornithine decarboxylase inhibitor
0,039  0,007  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,039  0,007  Retinoid X gamma receptor agonist
0,041  0,010  Adenosine uptake inhibitor
0,098  0,067  Estrogen receptor beta antagonist
0,076  0,045  Glycine receptor agonist
0,151  0,120  Antimitotic
0,045  0,015  RNA-directed RNA polymerase stimulant
0,036  0,007  Retinoid X gamma receptor antagonist
0,146  0,117  Septic shock treatment
0,030  0,004  Retinoid X beta receptor antagonist
0,161  0,136  Antihypercholesterolemic
0,108  0,085  Growth stimulant
0,030  0,007  Retinoic acid gamma receptor agonist
0,027  0,004  Vitamin D receptor agonist
0,030  0,008  Retinoid X beta receptor agonist
0,070  0,048  Anticholelithogenic
0,021  0,001  Vitamin D-like
0,028  0,008  Corticosteroid-like
0,041  0,022  Retinoid X receptor antagonist
0,037  0,019  Retinoid X alpha receptor antagonist
0,075  0,057  Estrogen receptor alpha antagonist
0,181  0,163  Antihypoxic
0,024  0,005  NMDA receptor phencyclidine site antagonist
0,028  0,011  Retinoic acid receptor agonist
0,098  0,080  GST T1-1 substrate
0,068  0,050  SULT2A1 substrate
0,049  0,032  Cholesterol esterase inhibitor
0,061  0,044  Heme oxygenase stimulant
0,105  0,089  Cholinergic antagonist
0,113  0,097  Skin whitener
0,040  0,026  AMPA 4 receptor antagonist
0,052  0,039  Nicotinic alpha3beta2 receptor antagonist
0,102  0,090  Acetylcholine antagonist
0,188  0,176  Cholesterol antagonist
0,022  0,011  Retinoic acid beta receptor agonist
0,202  0,192  GST M1-1 substrate
0,051  0,042  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,032  0,024  Melatonin 2 agonist
0,142  0,134  Toxic, respiratory center
0,036  0,029  Glucose-6-phosphate dehydrogenase inhibitor
0,037  0,031  GABA uptake inhibitor
0,068  0,062  CYP2A6 inhibitor
0,013  0,007  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,048  0,042  Protein 50S ribosomal subunit inhibitor
0,031  0,026  Estrogen receptor alpha agonist
0,009  0,008  Progesterone receptor A antagonist
0,060  0,059  Calcium channel P-type blocker
0,030  0,030  Glutamate (mGluR3) agonist

